Genentech · 15 hours ago
2026 Summer Intern - Cell Therapy and Synthetic Immunity
South San Francisco, CA
Internship
Onsite
Intern
$50/hr - $50/hr
Start in 2026 SummerGenentech is a leading biotechnology company focused on innovative medicines for patients worldwide. They are seeking a 2026 Summer Intern in the Cell Therapy and Synthetic Immunity group to implement AI/ML approaches in genomic sequence analysis and optimization, collaborating closely with scientists in the field.
BiotechnologyLife ScienceManufacturing
Responsibilities
The candidate will be responsible for implementing one or more AI/ML approaches in close collaboration with colleagues with and without expertise in AI/ML and bioinformatics
The candidate will be responsible for documenting their efforts and code effectively such that colleagues will be able to replicate their efforts before and after their departure
The candidate will be responsible for effectively communicating their technical and scientific findings in both smaller project meetings and larger group presentation formats
More detailed project objectives will be tailored to the candidate’s strengths, and an ideal outcome for the project would be significant contributions to a robust bioinformatic pipeline of patent or publication quality
Qualification
Required
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Bioinformatics, Computer Science or related fields, Biology
The candidate must be familiar with motif analysis and machine learning approaches
The candidate must be comfortable with programming in Python, R, and/or Julia, ideally in an HPC setting
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Expertise in machine learning, particularly sequencing-based approaches
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-23
Genetic Engineering News
2026-01-23
Company data provided by crunchbase